Zongwu Lin

1.9k total citations
61 papers, 1.3k citations indexed

About

Zongwu Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Zongwu Lin has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Zongwu Lin's work include Lung Cancer Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (18 papers) and Esophageal Cancer Research and Treatment (8 papers). Zongwu Lin is often cited by papers focused on Lung Cancer Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (18 papers) and Esophageal Cancer Research and Treatment (8 papers). Zongwu Lin collaborates with scholars based in China, United States and Ireland. Zongwu Lin's co-authors include Qun Wang, Cheng Zhan, Jie Gu, Wei Jiang, Di Ge, Zhencong Chen, Yiwei Huang, Zhengyang Hu, Yu Shi and Guangyin Zhao and has published in prestigious journals such as Cancer, Endocrinology and Cancer Letters.

In The Last Decade

Zongwu Lin

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zongwu Lin China 24 602 532 341 297 198 61 1.3k
Akikazu Kawase Japan 19 419 0.7× 593 1.1× 588 1.7× 269 0.9× 135 0.7× 59 1.3k
Shixiu Wu China 23 624 1.0× 545 1.0× 496 1.5× 472 1.6× 106 0.5× 71 1.6k
Gengtai Ye China 13 549 0.9× 344 0.6× 361 1.1× 373 1.3× 178 0.9× 22 1.1k
Lian Xu China 17 475 0.8× 314 0.6× 449 1.3× 316 1.1× 145 0.7× 40 1.1k
Lars Tharun Germany 15 471 0.8× 240 0.5× 434 1.3× 179 0.6× 118 0.6× 41 966
Diane Goltz Germany 21 594 1.0× 305 0.6× 489 1.4× 246 0.8× 331 1.7× 55 1.3k
Jeonghee Cho South Korea 18 685 1.1× 422 0.8× 518 1.5× 343 1.2× 175 0.9× 31 1.2k
Kunkun Sun China 16 409 0.7× 491 0.9× 402 1.2× 347 1.2× 210 1.1× 71 1.2k
Brian P. Adley United States 22 724 1.2× 405 0.8× 347 1.0× 313 1.1× 149 0.8× 30 1.5k

Countries citing papers authored by Zongwu Lin

Since Specialization
Citations

This map shows the geographic impact of Zongwu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongwu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongwu Lin more than expected).

Fields of papers citing papers by Zongwu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongwu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongwu Lin. The network helps show where Zongwu Lin may publish in the future.

Co-authorship network of co-authors of Zongwu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zongwu Lin. A scholar is included among the top collaborators of Zongwu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongwu Lin. Zongwu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
4.
Sui, Qihai, Zhengyang Hu, Jiaqi Liang, et al.. (2023). Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma. Cancer Letters. 581. 216497–216497. 14 indexed citations
5.
Zhang, Huan, Yunyi Bian, Jiaqi Liang, et al.. (2023). Hepatic nuclear factor 4 alpha promotes the ferroptosis of lung adenocarcinoma via transcriptional activation of cytochrome P450 oxidoreductase. PeerJ. 11. e15377–e15377. 5 indexed citations
6.
Sui, Qihai, Zhengyang Hu, Xing Jin, et al.. (2023). The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data. Cell & Bioscience. 13(1). 103–103. 7 indexed citations
7.
Sui, Qihai, Jiaqi Liang, Zhengyang Hu, et al.. (2021). The clinical prognostic factors of patients with stage IB lung adenocarcinoma. Translational Cancer Research. 10(11). 4727–4738. 6 indexed citations
8.
Chen, Zhencong, Yiwei Huang, Zhengyang Hu, et al.. (2021). Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy. Oncogenesis. 10(10). 71–71. 30 indexed citations
9.
Xi, Junjie, Jiacheng Yin, Jiaqi Liang, et al.. (2021). Prognostic Impact of Radiological Consolidation Tumor Ratio in Clinical Stage IA Pulmonary Ground Glass Opacities. Frontiers in Oncology. 11. 616149–616149. 27 indexed citations
10.
Hu, Zhengyang, Guoshu Bi, Qihai Sui, et al.. (2020). Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinoma. International Immunopharmacology. 88. 106910–106910. 7 indexed citations
11.
Sun, Fenghao, Yiwei Huang, Xiaodong Yang, et al.. (2020). Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma. Cancer Imaging. 20(1). 87–87. 23 indexed citations
12.
Wang, Lin, Cheng Zhan, Fenghao Sun, et al.. (2019). Clinical Factors Predictive of a Better Prognosis of Pulmonary Metastasectomy for Hepatocellular Carcinoma. The Annals of Thoracic Surgery. 108(6). 1685–1691. 14 indexed citations
13.
Gu, Jie, Wei Mao, Fengkai Xu, et al.. (2018). Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex. Cancer Letters. 443. 125–134. 48 indexed citations
14.
Sun, Fenghao, Cheng Zhan, Xiaodong Yang, et al.. (2016). Is routine dissection of the station 9 lymph nodes really necessary for primary lung cancer?. International Journal of Surgery. 34. 53–57. 10 indexed citations
15.
Guo, Jing, Jie Gu, Zongwu Lin, et al.. (2015). Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer. Tumor Biology. 37(5). 6371–6378. 27 indexed citations
16.
Lin, Zongwu, Lin Xu, & Qun Wang. (2015). Uniportal video-assisted thoracic lobectomy in a semiprone position for the treatment of a large intralobar pulmonary sequestration. Interactive Cardiovascular and Thoracic Surgery. 21(4). 542–544. 6 indexed citations
18.
Lin, Zongwu, Jie Gu, Ronghua Liu, et al.. (2014). Genome-wide screening and co-expression network analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma. Tumor Biology. 35(11). 10959–10968. 7 indexed citations
19.
Zhao, Guangyin, Zongwu Lin, Chunlai Lu, et al.. (2014). USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma. Tumor Biology. 36(3). 1721–1729. 68 indexed citations
20.
Gu, Jie, et al.. (2013). CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells. Diseases of the Esophagus. 27(3). 294–302. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026